RE:RE:RE:News outenice.. vegas is next!
VANCOUVER, British Columbia, Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. ("NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® and Nutritional High International Inc. (“Nutritional High”) (CSE: EAT, OTCQB: SPLIF, FRANKFURT: 2NU) are pleased to provide a further update on their previously announced partnership.
The initial production run for the newly developed chewable, sublingual cannabis product (“NU Tablets”) for distribution and sale in the state of California, is on track and underway at Nutritional High's FLI NorCal facility in Sacramento, California. Delivery of the first purchase orders are set for November 2018. Initial distribution by Nutritional High's distributor, Calyx, will begin to approximately 450 plus dispensaries across the state of California. Unveiling of the finished packaging and branding will be released prior to the first shipment to dispensaries.
NU Tablet product SKU (stock keeping unit) selections include varying flavor profiles for Sativa, Indica and a Hybrid, with each product SKU containing different amounts of cannabis, combined with NeutriSci's Cryolisation technology. The combination of NeutriSci’s IP and ingredients with Nutritional High’s cannabis distillate makes this product a first-of-its-kind. This ground-breaking product provides a measured and effective dose with the added health benefits and increased bio-availability of pterostilbene.
Retail pricing for the NU Tablets are being set by the dispensaries and will be consistent with pricing for other edible delivery forms of products with similar volumes of cannabis, which range from USD$26.00-$32.00 per unit.
Jim Frazier, CEO of Nutritional High commented, “We are pleased to add the NeutriSci Tablets to our product mix. While caffeine isn't permitted to be sold with THC, NeutriSci's proprietary all-natural products are ideal to allow customers a unique cannabis experience and energy boost. Next stop: Las Vegas!”
NeutriSci’s CEO, Glen Rehman stated, “We are very pleased to announce that manufacturing of the new sublingual melts using NeutriSci’s patent pending Cryolisation technology is underway with expected delivery and sales to begin as soon as the initial run is completed. We are confident that the relationship we have built with Nutritional High, along with the processes that have been put in place, will be able to handle the volumes of what we expect to be a very well received product. We are very excited to have California be the lead state for this product launch and look forward to adding more states in the days to come.”
NeutriSci also announces that it has granted a total of 3,225,000 incentive stock options to certain directors, officers, employees and consultants of NeutriSci. The options have an exercise price of $0.175 and expire in five years.